JPRN-UMIN000004399Completed未知
Effect of raloxifene on bone metabolism, lipid profile and glucose metabolism in postmenopausal women with type 2 diabetes mellitus - Effect of raloxifene on bone metabolism, lipid profile, and glucose metabolism in postmenopausal women with type 2 diabetes mellitus
niversity of Occupational and Environmental Health, Japan0 sites150 target enrollmentStarted: December 1, 2010Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 150
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- ot applicable to 80years-old (—)
- Sex
- Female
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1)history of phlebothrombosis (2) bed-ridden people (3)Anti-phospholipid antibody syndrome; (4)history of hypersensitivity to raloxifene or alfacalcidol (5)With effective drug of bone metabolism(bisphosphonates, vitaminK, estrogen, calcium, anabolic steroid, sex hormones)
Investigators
Similar Trials
Completed
Phase 4
Long Term Effects of Raloxifene Treatment on Bone QualityOsteoporosis, Post-MenopausalNCT00532428Eli Lilly and Company31
Completed
Phase 4
Effect of Raloxifene Plus Cholecalciferol and Cholecalciferol Alone on the Bone Mineral Density in Postmenopausal Women With OsteopeniaPostemenopusal Women With OsteopeniaNCT05386784Yonsei University112
Completed
Phase 3
Effects of Arzoxifene on Bone Mass and the UterusPostmenopausal Bone LossNCT00085956Eli Lilly and Company300
Recruiting
Not Applicable
Effects of Eldecalcitol and Raloxifene on the suppression of new vertebral fracture with osteoporosis in perimenopausal women or ovariectomy patients: Randomized controlled trialosteoporosis in perimenopausal women or ovariectomy patientsJPRN-UMIN000009378Tokyo Women's Medical University Hospital360
Completed
Phase 4
Raloxifene for Prevention of Bone Loss in Postmenopausal Patients Receiving Chronic Corticosteroid TherapyOsteoporosisNCT00371956Tuen Mun Hospital114